Related Experiment Video
Updated: Jul 31, 2025

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Geographic and Temporal Trends in COVID-Associated Acute Kidney Injury in the National COVID Cohort Collaborative
Yun J Yoo1, Kenneth J Wilkins2,3, Fadhl Alakwaa4
1Department of Biology, Stony Brook University, Stony Brook, New York.
Insights
The incidence of Acute Kidney Injury (AKI) in hospitalized COVID-19 patients varied significantly by region and time, with higher mortality observed in AKI patients. These trends evolved throughout the pandemic in the United States.
Area of Science:
- Nephrology
- Infectious Diseases
- Public Health
Background:
- Acute Kidney Injury (AKI) is a known risk factor for mortality in patients hospitalized with coronavirus disease 2019 (COVID-19).
- However, comprehensive data on the incidence, geographic distribution, and temporal trends of AKI in this population since the pandemic's onset remain limited.
Purpose of the Study:
- To investigate the incidence, geographic variations, and temporal changes of AKI in hospitalized COVID-19 patients in the United States.
- To analyze the association between AKI and mortality in this cohort.
Main Methods:
- Utilized electronic health record data from the National COVID Cohort Collaborative (N3C) for hospitalized adults with COVID-19 (March 2020 - January 2022).
- AKI was identified using serum creatinine levels and diagnosis codes.
- Data were analyzed across 16-week periods and four geographic regions (Northeast, Midwest, South, West) using multivariable models.
Main Results:
- Out of 336,473 patients, 38% were diagnosed with AKI. An additional 17% had AKI based on creatinine changes without a diagnosis code, also showing higher mortality.
- AKI incidence peaked in the initial period (47%) and decreased thereafter.
- The South and West regions consistently showed higher adjusted odds of AKI compared to the Midwest, particularly in later periods.
Conclusions:
- The incidence and geographic distribution of COVID-19-associated AKI have shifted since the pandemic's initial wave.
- AKI, regardless of diagnostic method, is significantly associated with increased mortality in hospitalized COVID-19 patients.
Background:
AKI is associated with mortality in patients hospitalized with coronavirus disease 2019 (COVID-19); however, its incidence, geographic distribution, and temporal trends since the start of the pandemic are understudied.
Methods:
Electronic health record data were obtained from 53 health systems in the United States in the National COVID Cohort Collaborative. We selected hospitalized adults diagnosed with COVID-19 between March 6, 2020, and January 6, 2022. AKI was determined with serum creatinine and diagnosis codes. Time was divided into 16-week periods (P1-6) and geographical regions into Northeast, Midwest, South, and West. Multivariable models were used to analyze the risk factors for AKI or mortality.
Results:
Of a total cohort of 336,473, 129,176 (38%) patients had AKI. Fifty-six thousand three hundred and twenty-two (17%) lacked a diagnosis code but had AKI based on the change in serum creatinine. Similar to patients coded for AKI, these patients had higher mortality compared with those without AKI. The incidence of AKI was highest in P1 (47%; 23,097/48,947), lower in P2 (37%; 12,102/32,513), and relatively stable thereafter. Compared with the Midwest, the Northeast, South, and West had higher adjusted odds of AKI in P1. Subsequently, the South and West regions continued to have the highest relative AKI odds. In multivariable models, AKI defined by either serum creatinine or diagnostic code and the severity of AKI was associated with mortality.
Conclusions:
The incidence and distribution of COVID-19-associated AKI changed since the first wave of the pandemic in the United States.
Podcast:
This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/CJASN/2023_08_08_CJN0000000000000192.mp3.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management

